Mark Watkins-Fischl
Scientist of Purification Process Development at Medarex
Articles
Optimizing the Primary Recovery Step in Nonaffinity Purification Schemes for HuMAbs
Jue (Michelle) Wang, PhD;Deborah Perkins;Deena Aguiar;Mark Watkins-Fischl;Timothy Diehl;Alahari Arunakumari, PhD
March 2nd 2008An alternative approach to traditional Protein A schemes is comparable in overall efficiency, product recovery, and quality.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
